TNFSF10 and neoplasm: While tumor necrosis factor-related apoptosis inducing ligand (TRAIL) selectively induces apoptosis of tumor cells [9,11,49,50], approximately 20% of them develop resistance to TRAIL, limiting its potential use in clinic [22,49,51].